We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.92B
AUM Growth
+$154M
Cap. Flow
+$62.7M
Cap. Flow %
3.27%
Top 10 Hldgs %
26.22%
Holding
151
New
15
Increased
40
Reduced
15
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 36.8%
2 Consumer Discretionary 13.92%
3 Technology 13.08%
4 Industrials 10.12%
5 Utilities 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$28.1M 1.46%
525,000
INST
27
DELISTED
Instructure, Inc.
INST
$27.9M 1.45%
842,000
XLRN
28
DELISTED
Acceleron Pharma
XLRN
$27.8M 1.45%
653,900
SPLK
29
DELISTED
Splunk Inc
SPLK
$27.4M 1.43%
331,000
VRTX icon
30
Vertex Pharmaceuticals
VRTX
$122B
$27M 1.41%
180,000
IDTI
31
DELISTED
Integrated Device Technology I
IDTI
$24.6M 1.28%
826,000
LOXO
32
DELISTED
Loxo Oncology, Inc
LOXO
$24M 1.25%
285,000
ARW icon
33
Arrow Electronics
ARW
$10.9B
$23.7M 1.24%
295,000
CAFD
34
DELISTED
8point3 Energy Partners LP
CAFD
$22.2M 1.16%
1,461,400
+2,800
+0.2% +$42.1K
PEGI
35
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$22M 1.15%
1,024,500
+129,500
+14% +$2.91M
ELLI
36
DELISTED
Ellie Mae Inc
ELLI
$21.6M 1.13%
242,000
IPHI
37
DELISTED
INPHI CORPORATION
IPHI
$20.3M 1.06%
555,000
JELD icon
38
JELD-WEN Holding
JELD
$117M
$19.9M 1.04%
+506,500
New +$18.8M
CRUS icon
39
Cirrus Logic
CRUS
$6.65B
$19.2M 1%
370,000
HUBS icon
40
HubSpot
HUBS
$11.9B
$18.4M 0.96%
208,000
AY
41
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$17.1M 0.89%
805,500
-2,500
-0.3% -$54.6K
STML
42
DELISTED
Stemline Therapeutics, Inc.
STML
$16.9M 0.88%
1,086,400
HASI icon
43
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$16.8M 0.87%
697,200
-7,800
-1% -$187K
ONCE
44
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$16.7M 0.87%
324,000
SAGE
45
CALL
DELISTED
Sage Therapeutics
SAGE
$16.5M 0.86%
+100,000
New +$9.7M
LII icon
46
Lennox International
LII
$14.5B
$15.6M 0.81%
+75,000
New +$14.6M
WVE icon
47
Wave Life Sciences
WVE
$1.11B
$15.2M 0.79%
433,500
FIVN icon
48
FIVE9
FIVN
$2.12B
$14.3M 0.75%
576,000
VMC icon
49
Vulcan Materials
VMC
$35.2B
$14.1M 0.74%
110,000
PFPT
50
DELISTED
Proofpoint, Inc.
PFPT
$14M 0.73%
158,000

Similar funds

Eventide Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Eventide Asset Management held 151 positions worth $1.92B, up 8.7% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $62.7M of net new capital in Q4 2017, opening 15 new positions and adding to 40 existing holdings. Its largest new stake was JELD-WEN Holding: 506,500 shares worth $19.9M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was bluebird bio, an estimated $21.1M trimmed.

  • Eventide Asset Management's largest Q4 2017 buy was JELD-WEN Holding: 506,500 shares worth $19.9M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q4 2017, an estimated $8.18M increase.
  • Eventide Asset Management's biggest Q4 2017 reduction was bluebird bio, cutting an estimated $21.1M.
  • Eventide Asset Management fully exited CyberArk in Q4 2017, selling an estimated $14M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.92B portfolio in Q4 2017.
  • Eventide Asset Management opened 15 new positions and closed 11 in Q4 2017.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $1.92B.

Based on Eventide Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.